When architects create plans for a new building, they typically work with an engineer to design the structure so that the ...

Canva today unveiled Canva Code 2.0, an AI-powered vibe coding platform that lets users build and visually edit websites, ...

The first time a top-10 drugmaker called AI scientist company FutureHouse, offering $30 million to use the nonprofit’s artificial intelligence agents for drug discovery, CEO Sam Rodriques thought ...

A polar bear swims underwater in the St-Felicien Wildlife Zoo in St-Felicien, Quebec, Oct. 31, 2011. The famous creature will be a part of those housed in a genomic and cellular "biovault," which was ...

Cate Blanchett, among her litany of talents and accolades, is aware she's not the savviest when it comes to technology. That doesn't mean she doesn't understand when technology begets a problem, ...

CHICAGO & ITASCA, Ill., June 22, 2026--(BUSINESS WIRE)--Syntax Bio, a synthetic biology company programming the next generation of cell therapies, and Ajinomoto Health & Nutrition North America, Inc. ...

From chemical building blocks, scientists have created synthetic cells that have most of the hallmarks of life.

Microsoft announced Wednesday that over the past two decades, it has become dramatically more efficient in its use of water to cool data centers, slashing its consumption rate by 90% compared to ...

German drugmaker Merck KGaA said on Thursday it will acquire U.S. biotech firm Bio-Techne for $11.3 billion, its largest deal in over a decade, as it looks to strengthen its life sciences business.

Microsoft MSFT0.19%increase; up pointing triangle, Google and Amazon AMZN-0.69%decrease; down pointing triangle are among the tech companies spending an estimated $1 trillion on AI infrastructure this ...

Nvidia just announced a warm-water cooling system that it says can dramatically reduce the amount of water a data center uses — eliminating “pretty much all water usage” inside the data center, ...

SAN DIEGO and NEW YORK, June 23, 2026 (GLOBE NEWSWIRE) -- Boundless Bio, Inc. (Nasdaq: BOLD) and Serapha Bio, Inc., a privately held biotechnology company developing an investigational in vivo base ...